Post-IPO Debt Funded Health Care Startups
Across these 19 post-IPO debt rounds in health care (latest on 2022-10-21 with Skylight Health Group at $3M; oldest on 2022-02-22 with Amryt Pharma), the d…
Across these 19 post-IPO debt rounds in health care (latest on 2022-10-21 with Skylight Health Group at $3M; oldest on 2022-02-22 with Amryt Pharma), the disclosed amounts cluster tightly below $250M, with one major outlier: Owens & Minor’s $500M post-IPO debt round on 2022-03-18. Tricida ($125M, 2022-10-19), Verano Holdings ($100M, 2022-03-02), Quipt Home Medical ($110M, 2022-09-19), and HEXO ($155M, 2022-07-12) sit in the next tier, but none match Owens & Minor.
Date-wise, activity is heaviest in the second half of 2022: 10 of the 19 rounds land between 2022-07-01 and 2022-10-21, including multiple high-ticket entries in late September (Quipt Home Medical at $110M on 2022-09-19 and Tricida at $125M on 2022-10-19). The list is also geographically concentrated in Canada (Skylight Health Group, Think Research, HEXO, Medx Health, Smart Employee Benefits) and includes two notable Ireland-based entries (DeepVerge on 2022-03-19 and Amryt Pharma on 2022-02-22).
Most recent rounds
19 shownRelated listings
Frequently asked
Which recent post-IPO debt round is the clear size outlier, and what does it imply versus the rest of the disclosed amounts?
Owens & Minor’s $500M post-IPO debt round on 2022-03-18 is the only disclosed amount in the $500M range here; the next-largest disclosed rounds are Bioventus at $415M (2022-04-26) and then HEXO at $155M (2022-07-12), making the $500M figure materially above the rest.
Do the dates show clustering in a particular window within the 19 most recent entries?
Yes. Ten of the 19 rounds occur between 2022-07-01 and 2022-10-21, including a late-September cluster with Quipt Home Medical at $110M (2022-09-19) plus Think Research’s undisclosed amount on 2022-09-26.
Are any cities (or countries) over-represented in this list?
Canada is over-represented by country count: Skylight Health Group (Mississauga, 2022-10-21, $3M), Think Research (Toronto, 2022-09-26, undisclosed), HEXO (Gatineau, 2022-07-12, $155M), Medx Health (Mississauga, 2022-03-22, $1M), and Smart Employee Benefits (Mississauga, 2022-03-09, $5M). Ireland also appears twice: DeepVerge ($33M on 2022-03-19) and Amryt Pharma ($125M on 2022-02-22).
How many rounds are undisclosed or at the low end, and how does that affect comparisons?
One round is undisclosed: Think Research on 2022-09-26. Among disclosed amounts, the smallest disclosed entry is Delic Corp at $1M on 2022-07-27, while several late-2022 rounds are far higher (e.g., Quipt Home Medical at $110M on 2022-09-19 and Tricida at $125M on 2022-10-19), so low disclosed values create a long left tail.
Is there a tighter grouping of high-disclosed rounds around specific months?
High disclosed amounts repeat in mid-to-late 2022 rather than being evenly spread: HEXO at $155M (2022-07-12), TransMedics at $60M (2022-09-15), Quipt Home Medical at $110M (2022-09-19), and Tricida at $125M (2022-10-19). In contrast, March 2022 includes both extremes like Owens & Minor at $500M (2022-03-18) and Medx Health at $1M (2022-03-22).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.